speb/financial-data huggingface dataset:
CRIS income_statement (annual, 2025-12-31) — Net Income: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 19356000.00
CRIS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -7582000.00
CRIS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 19356000.00
CRIS income_statement (annual, 2025-12-31) — Net Interest Income: -1869000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2134000.00
CRIS cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CRIS cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CRIS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1869000.00
CRIS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2134000.00
CRIS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -5587000.00
CRIS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CRIS balance_sheet (annual, 2025-12-31) — Net PPE: 1952000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Net PPE: 1952000.00
CRIS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -3520000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -3520000.00
CRIS income_statement (annual, 2025-12-31) — Normalized EBITDA: -32417000.00
CRIS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 19971000.00
CRIS income_statement (annual, 2025-12-31) — Normalized Income: -34771000.00
CRIS income_statement (quarterly, 2025-12-31) — Normalized Income: 19356000.00
CRIS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -27201000.00
CRIS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -6371000.00
CRIS income_statement (annual, 2025-12-31) — Operating Income: -32902000.00
CRIS income_statement (quarterly, 2025-12-31) — Operating Income: -7570000.00
CRIS income_statement (annual, 2025-12-31) — Operating Revenue: 9443000.00
CRIS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1138000.00
CRIS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 646442.00
CRIS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 646442.00
CRIS balance_sheet (annual, 2025-12-31) — Other Current Assets: 1854000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1854000.00
CRIS income_statement (annual, 2025-12-31) — Other Gand A: 6583000.00
CRIS income_statement (quarterly, 2025-12-31) — Other Gand A: 1658000.00
CRIS income_statement (annual, 2025-12-31) — Other Income Expense: 27189000.00
CRIS income_statement (quarterly, 2025-12-31) — Other Income Expense: 29060000.00
CRIS cash_flow (annual, 2025-12-31) — Other Non Cash Items: -25556000.00
CRIS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -26542000.00
CRIS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 2117000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 2117000.00
CRIS balance_sheet (annual, 2025-12-31) — Other Properties: 1890000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Other Properties: 1890000.00
CRIS income_statement (annual, 2025-12-31) — Other Special Charges: -27189000.00
CRIS balance_sheet (annual, 2025-12-31) — Payables: 5612000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Payables: 5612000.00
CRIS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 12886000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 12886000.00
CRIS balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRIS balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRIS income_statement (annual, 2025-12-31) — Pretax Income: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Pretax Income: 19356000.00
CRIS balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRIS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRIS cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CRIS cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CRIS balance_sheet (annual, 2025-12-31) — Receivables: 0.00
CRIS balance_sheet (quarterly, 2025-12-31) — Receivables: 0.00
CRIS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 45000.00
CRIS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 0.00
CRIS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 169000.00
CRIS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 36000.00
CRIS income_statement (annual, 2025-12-31) — Research And Development: 28254000.00
CRIS income_statement (quarterly, 2025-12-31) — Research And Development: 5825000.00
CRIS balance_sheet (annual, 2025-12-31) — Retained Earnings: -1247381000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1247381000.00
CRIS income_statement (annual, 2025-12-31) — Salaries And Wages: 6722000.00
CRIS income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1068000.00
CRIS cash_flow (annual, 2025-12-31) — Sale Of Business: 2500000.00
CRIS cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
CRIS cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CRIS income_statement (annual, 2025-12-31) — Selling General And Administration: 14046000.00
CRIS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2883000.00
CRIS balance_sheet (annual, 2025-12-31) — Share Issued: 646442.00
CRIS balance_sheet (quarterly, 2025-12-31) — Share Issued: 646442.00
CRIS income_statement (annual, 2025-12-31) — Special Income Charges: 27189000.00
CRIS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 4018000.00
CRIS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 795000.00
CRIS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5462000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5462000.00
CRIS balance_sheet (annual, 2025-12-31) — Tangible Book Value: -3520000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -3520000.00
CRIS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
CRIS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CRIS balance_sheet (annual, 2025-12-31) — Total Assets: 19966000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Assets: 19966000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Capitalization: 5462000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 5462000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Debt: 1618000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Debt: 1618000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5462000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5462000.00
CRIS income_statement (annual, 2025-12-31) — Total Expenses: 42345000.00
CRIS income_statement (quarterly, 2025-12-31) — Total Expenses: 8708000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14504000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14504000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 13051000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 13051000.00
CRIS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 428000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 428000.00
CRIS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -5713000.00
CRIS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 19619000.00
CRIS income_statement (annual, 2025-12-31) — Total Unusual Items: 27189000.00
CRIS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 27189000.00
CRIS balance_sheet (annual, 2025-12-31) — Working Capital: -7161000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Working Capital: -7161000.00
CRIS income_statement (quarterly, 2026-03-31) — +Operating Expense: 11519000.00
CRIS income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
CRIS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 6742000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1283887000.00
CRIS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 968173.00
CRIS income_statement (quarterly, 2026-03-31) — Basic EPS: -25.00
CRIS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5605000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1337000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 400000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 15001000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 15001000.00
CRIS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 18941000.00
CRIS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -9001000.00
CRIS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -281000.00
CRIS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 521000.00
CRIS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -126000.00
CRIS cash_flow (quarterly, 2026-03-31) — Change In Receivables: 0.00
CRIS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 114000.00
CRIS cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 0.00
CRIS cash_flow (quarterly, 2026-03-31) — Changes In Cash: 9940000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Common Stock: 400000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 12707000.00
CRIS cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 18941000.00
CRIS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 0.00
CRIS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5651000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Current Assets: 16611000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1229000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1229000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 14974000.00
CRIS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 8000.00
CRIS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 8000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 1897000.00
CRIS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 968173.00
CRIS income_statement (quarterly, 2026-03-31) — Diluted EPS: -25.00
CRIS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — EBIT: -11519000.00
CRIS income_statement (quarterly, 2026-03-31) — EBITDA: -11511000.00
CRIS cash_flow (quarterly, 2026-03-31) — End Cash Position: 15545000.00
CRIS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 18941000.00
CRIS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -9001000.00
CRIS cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 12757000.00
CRIS income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -12757000.00
CRIS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5070000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Goodwill: 8982000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1606000.00
CRIS income_statement (quarterly, 2026-03-31) — Gross Profit: 0.00
CRIS income_statement (quarterly, 2026-03-31) — Insurance And Claims: 156000.00
CRIS income_statement (quarterly, 2026-03-31) — Interest Income: 77000.00
CRIS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 77000.00
CRIS cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
CRIS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 12707000.00
CRIS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 0.00
CRIS cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 18941000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 108000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 108000.00
CRIS cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 18941000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -24199000.00
CRIS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Interest Income: 77000.00
CRIS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 77000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Net PPE: 1606000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3725000.00
CRIS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1246000.00
CRIS income_statement (quarterly, 2026-03-31) — Normalized Income: -11442000.00
CRIS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -9001000.00
CRIS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 12757000.00
CRIS income_statement (quarterly, 2026-03-31) — Operating Income: -11519000.00
CRIS income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
CRIS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1998934.00
CRIS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1610000.00
CRIS income_statement (quarterly, 2026-03-31) — Other Gand A: 3147000.00
CRIS income_statement (quarterly, 2026-03-31) — Other Income Expense: -12757000.00
CRIS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 1744000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2487000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Other Properties: 1606000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Payables: 6742000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 12393000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1352000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CRIS income_statement (quarterly, 2026-03-31) — Pretax Income: -24199000.00
CRIS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 0.00
CRIS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 8000.00
CRIS income_statement (quarterly, 2026-03-31) — Research And Development: 6449000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1271580000.00
CRIS income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1767000.00
CRIS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5070000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Share Issued: 1998934.00
CRIS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 575000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12707000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3725000.00
CRIS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Assets: 29686000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 12707000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1337000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 12707000.00
CRIS income_statement (quarterly, 2026-03-31) — Total Expenses: 11519000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16979000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13075000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2005000.00
CRIS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -11519000.00
CRIS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -12757000.00
CRIS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12757000.00
CRIS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1637000.00
CRISIL.NS balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 0.00
CRISIL.NS balance_sheet (annual, 2021-12-31) — Hedging Assets Current: 129000000.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 0.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 22300000.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 74900000.00
CRISIL.NS balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 5000000.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CRISIL.NS cash_flow (annual, 2021-12-31) — Stock Based Compensation: 15700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — +Operating Expense: 7501500000.00
CRISIL.NS income_statement (annual, 2022-12-31) — +Total Revenue: 27687200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Accounts Payable: 1420000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 7588300000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3365800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3535500000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -238100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Amortization: 267600000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 1907700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Basic Average Shares: 73006144.00
CRISIL.NS income_statement (annual, 2022-12-31) — Basic EPS: 77.31
CRISIL.NS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2899200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 2800300000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Capital Expenditure: -411400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 834600000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Capital Stock: 73100000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3192500000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 8430400000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -3431400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1486800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Cash Financial: 1705700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -358500000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 1161000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Change In Payable: 92800000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Change In Receivables: -2174000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Change In Working Capital: -1123100000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Changes In Cash: 263800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Common Stock: 73100000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 17919800000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 355100000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Construction In Progress: 9700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Cost Of Revenue: 13910000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Assets: 17612000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 595700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 595700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Deferred Taxes Liabilities: 119900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Liabilities: 9438000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Current Provisions: 870500000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Depreciation: 1033100000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1033100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1033100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Depreciation Income Statement: 765500000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Diluted Average Shares: 73051258.00
CRISIL.NS income_statement (annual, 2022-12-31) — Diluted EPS: 77.26
CRISIL.NS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 5643900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Dividends Payable: 7300000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 27200000.00
CRISIL.NS income_statement (annual, 2022-12-31) — EBIT: 7488000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — EBITDA: 8521100000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 29500000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — End Cash Position: 3192500000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -3683200000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Free Cash Flow: 4152000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -191300000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -11400000.00
CRISIL.NS income_statement (annual, 2022-12-31) — General And Administrative Expense: 1385700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Goodwill: 3798300000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4986000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 7826400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Gross PPE: 4715200000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Gross Profit: 13777200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 0.00
CRISIL.NS income_statement (annual, 2022-12-31) — Interest Expense: 64000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 64000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Interest Income: 36000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 36000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Interest Paid Cff: -64000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Interest Received Cfi: 12400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Invested Capital: 17919800000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -616400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 1907700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 355100000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 238900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 238900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Long Term Provisions: 288800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1905200000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -11000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 355100000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -484700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income: 5643900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 5643900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 5643900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 5643900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 5643900000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 7424000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 5643900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Interest Income: -28000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -256100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -28000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 400000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -11000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Net PPE: 1349400000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -388900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 12933800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 1000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 793900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 288800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1656400000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Normalized EBITDA: 8339300000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Normalized Income: 5505691349.68
CRISIL.NS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 4563400000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Operating Income: 6275700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Operating Revenue: 27687200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 73064044.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Other Cash Adjustment Inside Changein Cash: 0.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Current Assets: 1544300000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 786100000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Equity Interest: 328700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1187700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 21700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 21800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 309700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Other Operating Expenses: 3008900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Payable: 3085400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Properties: 1339700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Receivables: 285400000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 5237900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Other Special Charges: -17700000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Payables: 4512700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 870500000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1291200000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Pretax Income: 7424000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 99700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Purchase Of Business: -11000000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -267800000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -411400000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 13910000000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1033100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Rent And Landing Fees: 84900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 84900000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Restricted Cash: 16700000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Retained Earnings: 15206800000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Sale Of Investment: 11700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Sale Of PPE: 22500000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 80600000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Selling General And Administration: 1466300000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Share Issued: 73064044.00
CRISIL.NS income_statement (annual, 2022-12-31) — Special Income Charges: 17700000.00
CRISIL.NS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 17919800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 12933800000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 43591349.68
CRISIL.NS income_statement (annual, 2022-12-31) — Tax Provision: 1780100000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.24
CRISIL.NS cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -2204800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Assets: 28310000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Capitalization: 17919800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Debt: 834600000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 17919800000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Total Expenses: 21411500000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10390200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 10698000000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 952200000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 119900000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Total Unusual Items: 181800000.00
CRISIL.NS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 181800000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 423500000.00
CRISIL.NS balance_sheet (annual, 2022-12-31) — Working Capital: 8174000000.00
CRISIL.NS income_statement (annual, 2023-12-31) — +Operating Expense: 7992000000.00
CRISIL.NS income_statement (annual, 2023-12-31) — +Total Revenue: 31395200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Accounts Payable: 1425600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 6723800000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -2473500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3650500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -188100000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Amortization: 264000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 2781300000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Basic Average Shares: 73094435.00
CRISIL.NS income_statement (annual, 2023-12-31) — Basic EPS: 90.08
CRISIL.NS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3192500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1698200000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Capital Expenditure: -629400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 473200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Capital Stock: 73100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3658300000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 11518500000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -3581600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 2162800000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Cash Financial: 1495500000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -585100000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 1003900000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Change In Payable: 1700000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Change In Receivables: 602800000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Change In Working Capital: 1248700000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Changes In Cash: 501100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Common Stock: 73100000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -3581600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 21892600000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 92000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Construction In Progress: 19100000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Cost Of Revenue: 15609500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Assets: 20801500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 165600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 165600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Deferred Taxes Liabilities: 38900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Liabilities: 9897600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Current Provisions: 1010900000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Depreciation: 1037800000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1037800000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1037800000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Depreciation Income Statement: 773800000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Diluted Average Shares: 73106836.00
CRISIL.NS income_statement (annual, 2023-12-31) — Diluted EPS: 90.07
CRISIL.NS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 6584400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Dividends Payable: 11200000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 83900000.00
CRISIL.NS income_statement (annual, 2023-12-31) — EBIT: 8713600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — EBITDA: 9751400000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -32400000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — End Cash Position: 3661200000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -4076800000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Free Cash Flow: 7173900000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -445100000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -31400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — General And Administrative Expense: 1428500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Goodwill: 4208000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5657500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 6911900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Gross PPE: 3490100000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Gross Profit: 15785700000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 1100000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Interest Expense: 36600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 36600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Interest Income: 88200000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 88200000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Interest Paid Cff: -36600000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Interest Received Cfi: 59900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Invested Capital: 21892600000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -3267300000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 2781300000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 92000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 307600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 307600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Long Term Provisions: 404000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1772800000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -327400000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 92000000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -183900000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income: 6584400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 6584400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6584400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 6584400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 6584400000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 8677000000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6584400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Interest Income: 51600000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -2492600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 51600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Net PPE: 1016600000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -591100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 16235100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 1900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 857300000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 404000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 1857600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Normalized EBITDA: 9344000000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Normalized Income: 6275251151.32
CRISIL.NS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 7803300000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Operating Income: 7793700000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Operating Revenue: 31395200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 73113605.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Other Cash Adjustment Inside Changein Cash: 41900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Current Assets: 2199300000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 883100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Equity Interest: 305700000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1449500000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Other Non Cash Items: -66400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 90500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1900000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 356200000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Other Operating Expenses: 3306100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Payable: 3576400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Properties: 997500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Receivables: 432500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 7860200000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Other Special Charges: -46200000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Payables: 5013200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1010900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2102700000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Pretax Income: 8677000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 8500000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Purchase Of Business: -327400000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -9050700000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -629400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 15609500000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1037800000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Rent And Landing Fees: 72700000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 72700000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Restricted Cash: 22900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Retained Earnings: 18201000000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Sale Of Investment: 6558100000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Sale Of PPE: 38300000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 75200000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Selling General And Administration: 1503700000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Share Issued: 73113605.00
CRISIL.NS income_statement (annual, 2023-12-31) — Special Income Charges: 46200000.00
CRISIL.NS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 100000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 21892600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 16235100000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 98251151.32
CRISIL.NS income_statement (annual, 2023-12-31) — Tax Provision: 2092600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.24
CRISIL.NS cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -2442000000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Assets: 32973900000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Capitalization: 21892600000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Debt: 473200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 21892600000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Total Expenses: 23601500000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 11081300000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 12172400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 1183700000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 38900000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Total Unusual Items: 407400000.00
CRISIL.NS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 407400000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 470200000.00
CRISIL.NS balance_sheet (annual, 2023-12-31) — Working Capital: 10903900000.00
CRISIL.NS income_statement (annual, 2024-12-31) — +Operating Expense: 8396700000.00
CRISIL.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 1821600000.00
CRISIL.NS income_statement (annual, 2024-12-31) — +Total Revenue: 32597800000.00
CRISIL.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 9129100000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Accounts Payable: 1759700000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 1759700000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 5497900000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 5497900000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -2407700000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -2407700000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 3686600000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 3686600000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -170300000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -170300000.00
CRISIL.NS income_statement (annual, 2024-12-31) — Amortization: 214000000.00
CRISIL.NS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 214000000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 3896600000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 3896600000.00
CRISIL.NS income_statement (annual, 2024-12-31) — Basic Average Shares: 73124217.00
CRISIL.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 73141276.00
CRISIL.NS income_statement (annual, 2024-12-31) — Basic EPS: 93.55
CRISIL.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 30.72
CRISIL.NS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3661200000.00
CRISIL.NS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4737800000.00
CRISIL.NS balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4737800000.00
CRISIL.NS cash_flow (annual, 2024-12-31) — Capital Expenditure: -1731600000.00